Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

merestinib MeSH Supplementary Concept Data 2026


MeSH Supplementary
merestinib
Unique ID
C586252
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C586252
Entry Term(s)
LY2801653
N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5 yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide
Registry Numbers
5OGS5K699E
Heading Mapped to
*Indazoles
Niacinamide / analogs & derivatives
Frequency
9
Note
in phase I clinical trials (2013); structure in first source
Source
Invest New Drugs. 2013 Aug;31(4):833-44.
Indexing Information
Antineoplastic Agents
Protein Kinase Inhibitors
Date Introduced
2014/02/09
Last Updated
2021/11/09
merestinib Preferred
N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5 yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide Broader
LY2801653 Narrower
page delivered in 0.004s